In Brief
This article was originally published in The Tan Sheet
Executive Summary
FTC asked to investigate Claritin ad with “Madagascar” film characters; DSM’s i-Health aces NAD BrainStrong review; regulatory pressure mounts on DMAA; Hawaii joins NPLEx; more news In Brief.
You may also be interested in...
DSM Makes Waves In Omega-3 Fish Oil With Ocean Nutrition Pick-Up
The Dutch ingredients company hopes to expand Ocean Nutrition Canada into a global omega-3 fish oil supplier for foods and supplements, as well as a source for pharma ingredients. With expiring IP on the Martek algal DHA process, DSM could be seeking a hedge.
In Brief
Okla. and Ala. limit PSE sales while Colo. and Hawaii consider NPLEx; Abbott, Biocon team on Indian nutrition R&D; Bunge leaves Solae stake to DuPont; Valeant buys AcneFree; more news In Brief.
U.S. Military Investigates Supplement Ingredient DMAA, Bans Sales
DoD suspends DMAA sales at military stores after regulators in Canada and New Zealand restricted access and as some U.S. firms change how they market and label the ingredient. These moves and the potential for an FDA review could lead to enforcement against DMAA similar to the 2004 ban against ephedra’s use in supplements.